Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products
CJEU Advocate General on Distributors’ Obligations for Medical Devices
by Jan Feuerhake, LL.M. (Melbourne) and Gabriel Danyeli, LL.M. (Köln/Istanbul Bilgi)
by multiple authors
by multiple authors
by Irina Rebin
by Irina Rebin